Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2332)	6/1/2010 1:11:50 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

RIGL was up 8.12% and is still up 5.98% with volume of 294Ks still below its ADV The stock is bouncing up from the $6.50 level and it traded for a while above the resistance at $7 <g> bigcharts.marketwatch.com It announced today the promotion of three members of senior management, effective immediately.<g> Raul R. Rodriguez has been named president in addition to his position of COO RIGL has been trimming its losses in the last 4Qs and revenues on the 1stQ were also helped with an amortization of the $100M upfront payment from AZN pursuant to the exclusive worldwide license agreement for R788 and other oral Syk inhibitors. (As of March 31, 2010, $96.7M of the upfront payment has been deferred.) RIGL expects this deferred amount will be fully recognized as revenue by Sep2010. The ACTAY is $12.91 But although it is expected that RIGL will be able to report earnings on the black around $0.55 vs. a L of $2.70 last Yr., the L for 2011 is still projected around $1.40 and the stock has a good amount of resistance from the $8 to the $10 level. bigcharts.marketwatch.com Bernard .